SIMILAR PATTERNS OF AMINO ACIDS FOR 4U14_A_0HKA2000

List of similar pattern of amino acids derived from ASSAM search

Hit pattern: 3D amino acid arrangements similar to known drug binding site

Query pattern: Residues from known binding site for annotated drug that match the hit pattern


(Click link on the last column to view superposed patterns of amino acids in NGL viewer)
(Note that only 3-12 residue patterns can be used for ASSAM searches)
Filter list by:
Hit Macromolecule/
Organism
Pfam Res. Interface HETATM RMSD Dali Z-score Seq. Identity (%) View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1a6c TOBACCO RINGSPOT
VIRUS CAPSID PROTEIN


(Tobacco
ringspot virus)
PF03391
(Nepo_coat)
PF03688
(Nepo_coat_C)
PF03689
(Nepo_coat_N)
5 ILE A 170
THR A 470
ALA A 135
ASN A 133
CYH A 129
None
1.38A 4u14A-1a6cA:
undetectable
4u14A-1a6cA:
22.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1by7 PROTEIN (PLASMINOGEN
ACTIVATOR
INHIBITOR-2)


(Homo sapiens)
PF00079
(Serpin)
5 ILE A 114
THR A 177
ALA A 201
ALA A 358
ASN A 200
None
1.48A 4u14A-1by7A:
undetectable
4u14A-1by7A:
21.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1cu1 PROTEIN
(PROTEASE/HELICASE
NS3)


(Hepacivirus C)
PF02907
(Peptidase_S29)
PF07652
(Flavi_DEAD)
5 ILE A 288
SER A 211
THR A 416
ALA A 233
TYR A 270
None
PO4  A 800 (-4.6A)
None
None
None
1.12A 4u14A-1cu1A:
0.0
4u14A-1cu1A:
20.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1d7w MYELOPEROXIDASE

(Homo sapiens)
PF03098
(An_peroxidase)
5 ILE C 413
ASP C 142
ALA A  63
ALA A  61
ASN A  66
None
1.25A 4u14A-1d7wC:
undetectable
4u14A-1d7wC:
22.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1e5m BETA KETOACYL ACYL
CARRIER PROTEIN
SYNTHASE II


(Synechocystis
sp. PCC 6803)
PF00109
(ketoacyl-synt)
PF02801
(Ketoacyl-synt_C)
5 ILE A  89
SER A  85
THR A 163
ALA A 146
ASN A 160
None
1.08A 4u14A-1e5mA:
undetectable
4u14A-1e5mA:
22.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1jmz AMINE DEHYDROGENASE

(Pseudomonas
putida)
PF08992
(QH-AmDH_gamma)
PF09098
(Dehyd-heme_bind)
PF09099
(Qn_am_d_aIII)
PF09100
(Qn_am_d_aIV)
PF14930
(Qn_am_d_aII)
5 ASP A  93
SER A  97
THR A  88
ALA G   5
ALA G   3
None
1.46A 4u14A-1jmzA:
undetectable
4u14A-1jmzA:
19.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1sgv TRNA PSEUDOURIDINE
SYNTHASE B


(Mycobacterium
tuberculosis)
PF01509
(TruB_N)
PF09142
(TruB_C)
PF16198
(TruB_C_2)
5 ASP A 279
THR A 242
ALA A 246
ALA A 248
TYR A 264
None
1.48A 4u14A-1sgvA:
undetectable
4u14A-1sgvA:
21.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1szq 2-METHYLCITRATE
DEHYDRATASE


(Escherichia
coli)
PF03972
(MmgE_PrpD)
5 THR A 229
ALA A 225
ALA A 224
TRP A  98
CYH A  57
None
1.33A 4u14A-1szqA:
0.0
4u14A-1szqA:
22.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1tmo TRIMETHYLAMINE
N-OXIDE REDUCTASE


(Shewanella
massilia)
PF00384
(Molybdopterin)
PF01568
(Molydop_binding)
5 ASP A 290
TYR A 284
THR A 251
ALA A 255
ALA A 257
None
1.47A 4u14A-1tmoA:
0.0
4u14A-1tmoA:
20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1uzr RIBONUCLEOTIDE
REDUCTASE R2-2 SMALL
SUBUNIT


(Mycobacterium
tuberculosis)
PF00268
(Ribonuc_red_sm)
5 ASP A  72
TYR A 110
SER A 109
ALA A 187
TRP A  36
FE  A1292 (-2.5A)
None
None
None
None
1.42A 4u14A-1uzrA:
2.3
4u14A-1uzrA:
20.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1v7v CHITOBIOSE
PHOSPHORYLASE


(Vibrio
proteolyticus)
PF06165
(Glyco_transf_36)
PF17167
(Glyco_hydro_36)
5 ASP A 667
TYR A 666
TRP A 650
THR A 321
ALA A 718
None
1.35A 4u14A-1v7vA:
undetectable
4u14A-1v7vA:
19.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1zvt TOPOISOMERASE IV
SUBUNIT A


(Escherichia
coli)
PF03989
(DNA_gyraseA_C)
5 ILE A 622
TYR A 602
SER A 598
ALA A 680
ALA A 679
None
1.46A 4u14A-1zvtA:
undetectable
4u14A-1zvtA:
18.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2bvt BETA-1,4-MANNANASE

(Cellulomonas
fimi)
PF02156
(Glyco_hydro_26)
5 ILE A   8
ASP A 241
TYR A 215
ALA A 152
ALA A 155
None
1.45A 4u14A-2bvtA:
undetectable
4u14A-2bvtA:
22.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2dvl ACYL-COA
DEHYDROGENASE


(Thermus
thermophilus)
PF00441
(Acyl-CoA_dh_1)
PF02770
(Acyl-CoA_dh_M)
PF02771
(Acyl-CoA_dh_N)
5 THR A 306
ALA A 309
ALA A 295
TRP A  67
TYR A  94
None
1.49A 4u14A-2dvlA:
3.5
4u14A-2dvlA:
23.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2gdz NAD+-DEPENDENT
15-HYDROXYPROSTAGLAN
DIN DEHYDROGENASE


(Homo sapiens)
PF00106
(adh_short)
5 SER A 123
THR A 162
ALA A 166
ALA A 168
ASN A 239
None
0.98A 4u14A-2gdzA:
undetectable
4u14A-2gdzA:
20.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2mqd UNCHARACTERIZED
PROTEIN


(Lactobacillus
reuteri)
no annotation 5 ILE A  54
TYR A  68
SER A  69
THR A  90
ALA A  32
None
1.48A 4u14A-2mqdA:
undetectable
4u14A-2mqdA:
15.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2oae DIPEPTIDYL PEPTIDASE
4


(Rattus
norvegicus)
PF00326
(Peptidase_S9)
PF00930
(DPPIV_N)
5 ILE A 325
ASP A 327
TRP A 335
THR A 219
ALA A 222
None
1.41A 4u14A-2oaeA:
undetectable
4u14A-2oaeA:
20.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2own PUTATIVE
OLEOYL-[ACYL-CARRIER
PROTEIN]
THIOESTERASE


(Lactobacillus
plantarum)
PF01643
(Acyl-ACP_TE)
5 TYR A  96
THR A   3
ALA A   6
ALA A   8
TYR A 111
None
None
GOL  A 270 (-3.9A)
None
GOL  A 269 ( 3.6A)
1.27A 4u14A-2ownA:
undetectable
4u14A-2ownA:
18.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2qny 3-OXOACYL-[ACYL-CARR
IER-PROTEIN]
SYNTHASE 3


(Mycobacterium
tuberculosis)
PF08541
(ACP_syn_III_C)
PF08545
(ACP_syn_III)
5 ILE A 280
SER A 279
ALA A 158
TYR A 304
CYH A 112
None
None
None
None
DFD  A 760 (-1.6A)
1.09A 4u14A-2qnyA:
undetectable
4u14A-2qnyA:
22.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3a9g PUTATIVE
UNCHARACTERIZED
PROTEIN


(Pyrobaculum
aerophilum)
PF07995
(GSDH)
5 ASP A 144
ALA A 172
ALA A 185
ASN A 153
TYR A 113
None
1.30A 4u14A-3a9gA:
undetectable
4u14A-3a9gA:
19.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3fha ENDO-BETA-N-ACETYLGL
UCOSAMINIDASE


(Glutamicibacter
protophormiae)
PF03644
(Glyco_hydro_85)
5 TYR A 299
ALA A  94
ALA A  60
ASN A 123
TYR A 205
None
1.36A 4u14A-3fhaA:
undetectable
4u14A-3fhaA:
19.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3qr2 BASIGIN

(Homo sapiens)
PF13927
(Ig_3)
5 ILE A  60
TYR A  64
SER A  70
ALA A   2
ALA A  25
None
1.49A 4u14A-3qr2A:
undetectable
4u14A-3qr2A:
13.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3sut BETA-HEXOSAMINIDASE

(Paenibacillus
sp. TS12)
PF00728
(Glyco_hydro_20)
PF02838
(Glyco_hydro_20b)
5 ILE A 153
SER A 154
ALA A  94
ALA A  95
ASN A 115
None
1.30A 4u14A-3sutA:
undetectable
4u14A-3sutA:
22.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3uon HUMAN M2 MUSCARINIC
ACETYLCHOLINE,
RECEPTOR T4 LYSOZYME
FUSION PROTEIN


(Escherichia
virus T4;
Homo sapiens)
PF00001
(7tm_1)
PF00959
(Phage_lysozyme)
5 ASP A 103
TYR A 104
ALA A 191
TYR A 426
CYH A 429
QNB  A1162 (-3.1A)
QNB  A1162 (-4.0A)
QNB  A1162 (-3.9A)
QNB  A1162 ( 4.2A)
QNB  A1162 ( 4.0A)
1.49A 4u14A-3uonA:
38.6
4u14A-3uonA:
73.62
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3uon HUMAN M2 MUSCARINIC
ACETYLCHOLINE,
RECEPTOR T4 LYSOZYME
FUSION PROTEIN


(Escherichia
virus T4;
Homo sapiens)
PF00001
(7tm_1)
PF00959
(Phage_lysozyme)
12 ILE A  72
ASP A 103
TYR A 104
SER A 107
TRP A 155
THR A 187
ALA A 191
ALA A 194
TRP A 400
ASN A 404
TYR A 426
CYH A 429
None
QNB  A1162 (-3.1A)
QNB  A1162 (-4.0A)
QNB  A1162 (-3.4A)
QNB  A1162 (-4.2A)
QNB  A1162 (-4.8A)
QNB  A1162 (-3.9A)
QNB  A1162 ( 4.0A)
QNB  A1162 (-4.7A)
QNB  A1162 (-2.9A)
QNB  A1162 ( 4.2A)
QNB  A1162 ( 4.0A)
0.91A 4u14A-3uonA:
38.6
4u14A-3uonA:
73.62
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3uon HUMAN M2 MUSCARINIC
ACETYLCHOLINE,
RECEPTOR T4 LYSOZYME
FUSION PROTEIN


(Escherichia
virus T4;
Homo sapiens)
PF00001
(7tm_1)
PF00959
(Phage_lysozyme)
7 ILE A  72
ASP A 103
TYR A 104
THR A 190
TRP A 400
ASN A 404
CYH A 429
None
QNB  A1162 (-3.1A)
QNB  A1162 (-4.0A)
QNB  A1162 (-4.3A)
QNB  A1162 (-4.7A)
QNB  A1162 (-2.9A)
QNB  A1162 ( 4.0A)
1.43A 4u14A-3uonA:
38.6
4u14A-3uonA:
73.62
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3uon HUMAN M2 MUSCARINIC
ACETYLCHOLINE,
RECEPTOR T4 LYSOZYME
FUSION PROTEIN


(Escherichia
virus T4;
Homo sapiens)
PF00001
(7tm_1)
PF00959
(Phage_lysozyme)
6 ILE A  72
TYR A 104
THR A 190
ALA A 194
TRP A 400
CYH A 429
None
QNB  A1162 (-4.0A)
QNB  A1162 (-4.3A)
QNB  A1162 ( 4.0A)
QNB  A1162 (-4.7A)
QNB  A1162 ( 4.0A)
1.49A 4u14A-3uonA:
38.6
4u14A-3uonA:
73.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3wwx S12 FAMILY PEPTIDASE

(Streptomyces
sp. 82F2)
PF00144
(Beta-lactamase)
5 ILE A 274
SER A 275
THR A  70
ALA A  60
ALA A 356
None
1.35A 4u14A-3wwxA:
undetectable
4u14A-3wwxA:
20.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4fdd TRANSPORTIN-1

(Homo sapiens)
PF03810
(IBN_N)
PF13513
(HEAT_EZ)
5 ILE A  91
THR A 144
ALA A 148
ALA A 151
TRP A 126
None
1.16A 4u14A-4fddA:
2.1
4u14A-4fddA:
20.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4gdn PROTEIN FLP

(Staphylococcus
aureus)
PF00144
(Beta-lactamase)
5 TYR A 190
THR A 329
ALA A  95
ALA A 265
ASN A  97
None
1.45A 4u14A-4gdnA:
undetectable
4u14A-4gdnA:
20.29
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4mqt MUSCARINIC
ACETYLCHOLINE
RECEPTOR M2


(Homo sapiens)
PF00001
(7tm_1)
5 ASP A 103
TYR A 104
ALA A 191
TYR A 426
CYH A 429
IXO  A 501 (-3.4A)
IXO  A 501 (-3.7A)
None
2CU  A 502 ( 3.9A)
IXO  A 501 (-3.5A)
1.17A 4u14A-4mqtA:
33.1
4u14A-4mqtA:
45.70
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4mqt MUSCARINIC
ACETYLCHOLINE
RECEPTOR M2


(Homo sapiens)
PF00001
(7tm_1)
6 ASP A 103
TYR A 104
SER A 107
ALA A 191
ALA A 194
TYR A 426
IXO  A 501 (-3.4A)
IXO  A 501 (-3.7A)
IXO  A 501 (-3.4A)
None
IXO  A 501 (-3.5A)
2CU  A 502 ( 3.9A)
0.99A 4u14A-4mqtA:
33.1
4u14A-4mqtA:
45.70
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4mqt MUSCARINIC
ACETYLCHOLINE
RECEPTOR M2


(Homo sapiens)
PF00001
(7tm_1)
7 ASP A 103
TYR A 104
SER A 107
ALA A 191
ASN A 404
TYR A 426
CYH A 429
IXO  A 501 (-3.4A)
IXO  A 501 (-3.7A)
IXO  A 501 (-3.4A)
None
IXO  A 501 (-3.0A)
2CU  A 502 ( 3.9A)
IXO  A 501 (-3.5A)
0.99A 4u14A-4mqtA:
33.1
4u14A-4mqtA:
45.70
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4mqt MUSCARINIC
ACETYLCHOLINE
RECEPTOR M2


(Homo sapiens)
PF00001
(7tm_1)
6 ASP A 103
TYR A 104
SER A 107
ALA A 191
TRP A 400
ASN A 404
IXO  A 501 (-3.4A)
IXO  A 501 (-3.7A)
IXO  A 501 (-3.4A)
None
IXO  A 501 (-4.6A)
IXO  A 501 (-3.0A)
1.23A 4u14A-4mqtA:
33.1
4u14A-4mqtA:
45.70
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4mqt MUSCARINIC
ACETYLCHOLINE
RECEPTOR M2


(Homo sapiens)
PF00001
(7tm_1)
5 ASP A 103
TYR A 104
TRP A 155
ALA A 191
TYR A 426
IXO  A 501 (-3.4A)
IXO  A 501 (-3.7A)
IXO  A 501 (-3.6A)
None
2CU  A 502 ( 3.9A)
1.13A 4u14A-4mqtA:
33.1
4u14A-4mqtA:
45.70
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4mqt MUSCARINIC
ACETYLCHOLINE
RECEPTOR M2


(Homo sapiens)
PF00001
(7tm_1)
7 ILE A  72
ASP A 103
TYR A 104
THR A 187
ALA A 191
ALA A 194
TYR A 426
None
IXO  A 501 (-3.4A)
IXO  A 501 (-3.7A)
None
None
IXO  A 501 (-3.5A)
2CU  A 502 ( 3.9A)
0.98A 4u14A-4mqtA:
33.1
4u14A-4mqtA:
45.70
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4mqt MUSCARINIC
ACETYLCHOLINE
RECEPTOR M2


(Homo sapiens)
PF00001
(7tm_1)
8 ILE A  72
ASP A 103
TYR A 104
THR A 187
ALA A 191
ASN A 404
TYR A 426
CYH A 429
None
IXO  A 501 (-3.4A)
IXO  A 501 (-3.7A)
None
None
IXO  A 501 (-3.0A)
2CU  A 502 ( 3.9A)
IXO  A 501 (-3.5A)
0.89A 4u14A-4mqtA:
33.1
4u14A-4mqtA:
45.70
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4mqt MUSCARINIC
ACETYLCHOLINE
RECEPTOR M2


(Homo sapiens)
PF00001
(7tm_1)
7 ILE A  72
ASP A 103
TYR A 104
THR A 187
ALA A 191
TRP A 400
ASN A 404
None
IXO  A 501 (-3.4A)
IXO  A 501 (-3.7A)
None
None
IXO  A 501 (-4.6A)
IXO  A 501 (-3.0A)
1.13A 4u14A-4mqtA:
33.1
4u14A-4mqtA:
45.70
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4mqt MUSCARINIC
ACETYLCHOLINE
RECEPTOR M2


(Homo sapiens)
PF00001
(7tm_1)
6 ILE A  72
ASP A 103
TYR A 104
TRP A 155
THR A 187
TRP A 400
None
IXO  A 501 (-3.4A)
IXO  A 501 (-3.7A)
IXO  A 501 (-3.6A)
None
IXO  A 501 (-4.6A)
1.34A 4u14A-4mqtA:
33.1
4u14A-4mqtA:
45.70
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4mqt MUSCARINIC
ACETYLCHOLINE
RECEPTOR M2


(Homo sapiens)
PF00001
(7tm_1)
6 ILE A  72
ASP A 103
TYR A 104
TRP A 155
THR A 187
TYR A 426
None
IXO  A 501 (-3.4A)
IXO  A 501 (-3.7A)
IXO  A 501 (-3.6A)
None
2CU  A 502 ( 3.9A)
1.03A 4u14A-4mqtA:
33.1
4u14A-4mqtA:
45.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4n4p ACYLNEURAMINATE
LYASE


(Mycoplasma
synoviae)
PF00701
(DHDPS)
5 ILE A 208
THR A  91
ALA A  95
ALA A  98
TYR A 139
None
0.94A 4u14A-4n4pA:
undetectable
4u14A-4n4pA:
23.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4q3r ARGINASE

(Schistosoma
mansoni)
PF00491
(Arginase)
5 ILE A 290
TRP A 152
THR A 137
ALA A 306
CYH A 332
None
1.50A 4u14A-4q3rA:
undetectable
4u14A-4q3rA:
22.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4tpg PROTON:OLIGOPEPTIDE
SYMPORTER POT FAMILY


(Shewanella
oneidensis)
PF00854
(PTR2)
5 ILE A 333
TYR A 291
THR A 296
ALA A 299
TYR A  29
None
1.48A 4u14A-4tpgA:
2.8
4u14A-4tpgA:
22.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4u16 MUSCARINIC
ACETYLCHOLINE
RECEPTOR
M3,LYSOZYME,MUSCARIN
IC ACETYLCHOLINE
RECEPTOR M3


(Escherichia
virus T4;
Rattus
norvegicus)
PF00001
(7tm_1)
PF00959
(Phage_lysozyme)
6 ASP A 147
TYR A 148
THR A 234
ALA A 238
TYR A 529
CYH A 532
3C0  A1202 (-3.4A)
3C0  A1202 (-3.7A)
None
3C0  A1202 (-3.5A)
3C0  A1202 (-3.7A)
3C0  A1202 (-3.6A)
1.26A 4u14A-4u16A:
36.2
4u14A-4u16A:
89.59
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4u16 MUSCARINIC
ACETYLCHOLINE
RECEPTOR
M3,LYSOZYME,MUSCARIN
IC ACETYLCHOLINE
RECEPTOR M3


(Escherichia
virus T4;
Rattus
norvegicus)
PF00001
(7tm_1)
PF00959
(Phage_lysozyme)
12 ILE A 116
ASP A 147
TYR A 148
SER A 151
TRP A 199
THR A 231
ALA A 235
ALA A 238
TRP A 503
ASN A 507
TYR A 529
CYH A 532
None
3C0  A1202 (-3.4A)
3C0  A1202 (-3.7A)
3C0  A1202 (-2.9A)
3C0  A1202 (-4.4A)
None
3C0  A1202 (-3.5A)
3C0  A1202 (-3.5A)
3C0  A1202 ( 4.0A)
3C0  A1202 (-2.9A)
3C0  A1202 (-3.7A)
3C0  A1202 (-3.6A)
0.47A 4u14A-4u16A:
36.2
4u14A-4u16A:
89.59
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4u16 MUSCARINIC
ACETYLCHOLINE
RECEPTOR
M3,LYSOZYME,MUSCARIN
IC ACETYLCHOLINE
RECEPTOR M3


(Escherichia
virus T4;
Rattus
norvegicus)
PF00001
(7tm_1)
PF00959
(Phage_lysozyme)
7 ILE A 116
ASP A 147
TYR A 148
THR A 234
ASN A 507
TYR A 529
CYH A 532
None
3C0  A1202 (-3.4A)
3C0  A1202 (-3.7A)
None
3C0  A1202 (-2.9A)
3C0  A1202 (-3.7A)
3C0  A1202 (-3.6A)
1.38A 4u14A-4u16A:
36.2
4u14A-4u16A:
89.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4zky PYRIDOXAMINE
5-PHOSPHATE OXIDASE


(Mycolicibacterium
smegmatis)
PF01243
(Putative_PNPOx)
5 ASP A  94
TRP A 137
ALA A   9
ALA A   6
TRP A  90
None
1.44A 4u14A-4zkyA:
undetectable
4u14A-4zkyA:
15.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5cbm M17 FAMILY
AMINOPEPTIDASE


(Plasmodium
falciparum)
PF00883
(Peptidase_M17)
5 ILE A 576
SER A 580
TRP A 581
ALA A 300
ALA A 299
None
1.49A 4u14A-5cbmA:
undetectable
4u14A-5cbmA:
23.67
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5cxv MUSCARINIC
ACETYLCHOLINE
RECEPTOR
M1,ENDOLYSIN,MUSCARI
NIC ACETYLCHOLINE
RECEPTOR M1


(Escherichia
virus T4;
Homo sapiens)
PF00001
(7tm_1)
PF00959
(Phage_lysozyme)
6 ASP A 105
TYR A 106
THR A 192
ALA A 196
TYR A 404
CYH A 407
0HK  A 501 (-3.0A)
0HK  A 501 (-3.4A)
0HK  A 501 (-4.0A)
0HK  A 501 (-3.6A)
0HK  A 501 (-3.6A)
0HK  A 501 (-3.7A)
1.28A 4u14A-5cxvA:
42.6
4u14A-5cxvA:
73.59
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5cxv MUSCARINIC
ACETYLCHOLINE
RECEPTOR
M1,ENDOLYSIN,MUSCARI
NIC ACETYLCHOLINE
RECEPTOR M1


(Escherichia
virus T4;
Homo sapiens)
PF00001
(7tm_1)
PF00959
(Phage_lysozyme)
11 ILE A  74
ASP A 105
TYR A 106
SER A 109
THR A 189
ALA A 193
ALA A 196
TRP A 378
ASN A 382
TYR A 404
CYH A 407
None
0HK  A 501 (-3.0A)
0HK  A 501 (-3.4A)
0HK  A 501 (-3.1A)
0HK  A 501 (-4.4A)
0HK  A 501 (-3.9A)
0HK  A 501 (-3.6A)
0HK  A 501 (-4.4A)
0HK  A 501 (-2.8A)
0HK  A 501 (-3.6A)
0HK  A 501 (-3.7A)
0.64A 4u14A-5cxvA:
42.6
4u14A-5cxvA:
73.59
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5cxv MUSCARINIC
ACETYLCHOLINE
RECEPTOR
M1,ENDOLYSIN,MUSCARI
NIC ACETYLCHOLINE
RECEPTOR M1


(Escherichia
virus T4;
Homo sapiens)
PF00001
(7tm_1)
PF00959
(Phage_lysozyme)
8 ILE A  74
ASP A 105
TYR A 106
THR A 192
TRP A 378
ASN A 382
TYR A 404
CYH A 407
None
0HK  A 501 (-3.0A)
0HK  A 501 (-3.4A)
0HK  A 501 (-4.0A)
0HK  A 501 (-4.4A)
0HK  A 501 (-2.8A)
0HK  A 501 (-3.6A)
0HK  A 501 (-3.7A)
1.25A 4u14A-5cxvA:
42.6
4u14A-5cxvA:
73.59
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5cxv MUSCARINIC
ACETYLCHOLINE
RECEPTOR
M1,ENDOLYSIN,MUSCARI
NIC ACETYLCHOLINE
RECEPTOR M1


(Escherichia
virus T4;
Homo sapiens)
PF00001
(7tm_1)
PF00959
(Phage_lysozyme)
11 ILE A  74
ASP A 105
TYR A 106
TRP A 157
THR A 189
ALA A 193
ALA A 196
TRP A 378
ASN A 382
TYR A 404
CYH A 407
None
0HK  A 501 (-3.0A)
0HK  A 501 (-3.4A)
0HK  A 501 (-4.0A)
0HK  A 501 (-4.4A)
0HK  A 501 (-3.9A)
0HK  A 501 (-3.6A)
0HK  A 501 (-4.4A)
0HK  A 501 (-2.8A)
0HK  A 501 (-3.6A)
0HK  A 501 (-3.7A)
0.55A 4u14A-5cxvA:
42.6
4u14A-5cxvA:
73.59
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5dsg MUSCARINIC
ACETYLCHOLINE
RECEPTOR
M4,ENDOLYSIN,ENDOLYS
IN,MUSCARINIC
ACETYLCHOLINE
RECEPTOR M4


(Escherichia
virus T4;
Homo sapiens)
PF00001
(7tm_1)
PF00959
(Phage_lysozyme)
6 ASP A 112
TYR A 113
THR A 199
ALA A 203
TYR A 439
CYH A 442
0HK  A1201 (-4.0A)
0HK  A1201 ( 3.2A)
OLC  A1208 (-4.4A)
0HK  A1201 (-3.6A)
0HK  A1201 (-3.6A)
0HK  A1201 (-3.6A)
1.38A 4u14A-5dsgA:
41.2
4u14A-5dsgA:
67.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5dsg MUSCARINIC
ACETYLCHOLINE
RECEPTOR
M4,ENDOLYSIN,ENDOLYS
IN,MUSCARINIC
ACETYLCHOLINE
RECEPTOR M4


(Escherichia
virus T4;
Homo sapiens)
PF00001
(7tm_1)
PF00959
(Phage_lysozyme)
11 ILE A  81
ASP A 112
TYR A 113
SER A 116
THR A 196
ALA A 200
ALA A 203
TRP A 413
ASN A 417
TYR A 439
CYH A 442
None
0HK  A1201 (-4.0A)
0HK  A1201 ( 3.2A)
0HK  A1201 (-3.3A)
P6G  A1205 (-4.6A)
0HK  A1201 ( 4.2A)
0HK  A1201 (-3.6A)
0HK  A1201 (-4.3A)
0HK  A1201 (-2.8A)
0HK  A1201 (-3.6A)
0HK  A1201 (-3.6A)
0.71A 4u14A-5dsgA:
41.2
4u14A-5dsgA:
67.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5dsg MUSCARINIC
ACETYLCHOLINE
RECEPTOR
M4,ENDOLYSIN,ENDOLYS
IN,MUSCARINIC
ACETYLCHOLINE
RECEPTOR M4


(Escherichia
virus T4;
Homo sapiens)
PF00001
(7tm_1)
PF00959
(Phage_lysozyme)
8 ILE A  81
ASP A 112
TYR A 113
THR A 199
TRP A 413
ASN A 417
TYR A 439
CYH A 442
None
0HK  A1201 (-4.0A)
0HK  A1201 ( 3.2A)
OLC  A1208 (-4.4A)
0HK  A1201 (-4.3A)
0HK  A1201 (-2.8A)
0HK  A1201 (-3.6A)
0HK  A1201 (-3.6A)
1.45A 4u14A-5dsgA:
41.2
4u14A-5dsgA:
67.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5dsg MUSCARINIC
ACETYLCHOLINE
RECEPTOR
M4,ENDOLYSIN,ENDOLYS
IN,MUSCARINIC
ACETYLCHOLINE
RECEPTOR M4


(Escherichia
virus T4;
Homo sapiens)
PF00001
(7tm_1)
PF00959
(Phage_lysozyme)
11 ILE A  81
ASP A 112
TYR A 113
TRP A 164
THR A 196
ALA A 200
ALA A 203
TRP A 413
ASN A 417
TYR A 439
CYH A 442
None
0HK  A1201 (-4.0A)
0HK  A1201 ( 3.2A)
OLC  A1208 ( 4.0A)
P6G  A1205 (-4.6A)
0HK  A1201 ( 4.2A)
0HK  A1201 (-3.6A)
0HK  A1201 (-4.3A)
0HK  A1201 (-2.8A)
0HK  A1201 (-3.6A)
0HK  A1201 (-3.6A)
0.64A 4u14A-5dsgA:
41.2
4u14A-5dsgA:
67.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5hiw CYTOCHROME P450
CYP260B1


(Sorangium
cellulosum)
PF00067
(p450)
5 ILE A 298
THR A 232
ALA A 275
ALA A 276
TYR A  63
None
HEM  A 401 (-3.7A)
HEM  A 401 ( 4.1A)
None
HEM  A 401 (-4.4A)
1.45A 4u14A-5hiwA:
undetectable
4u14A-5hiwA:
23.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5hw3 BETA-LACTAMASE

(Burkholderia
vietnamiensis)
PF13354
(Beta-lactamase2)
5 ILE A 220
TYR A 245
THR A 161
ALA A 184
ALA A 187
None
1.49A 4u14A-5hw3A:
undetectable
4u14A-5hw3A:
20.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5jsc PUTATIVE ACYL-COA
DEHYDROGENASE


(Paraburkholderia
xenovorans)
PF00441
(Acyl-CoA_dh_1)
PF02770
(Acyl-CoA_dh_M)
PF02771
(Acyl-CoA_dh_N)
5 ILE A 367
SER A 261
ALA A 327
ALA A 330
TYR A 373
None
None
None
None
FAD  A 500 (-4.7A)
1.31A 4u14A-5jscA:
3.4
4u14A-5jscA:
21.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5m6q UNCHARACTERIZED
PROTEIN


(Kutzneria
albida)
PF09017
(Transglut_prok)
5 ASP A 182
TRP A 178
ALA A 125
ALA A 223
ASN A  82
None
1.44A 4u14A-5m6qA:
undetectable
4u14A-5m6qA:
18.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5mfa MYELOPEROXIDASE

(Homo sapiens)
PF03098
(An_peroxidase)
5 ILE A 579
ASP A 308
ALA A 229
ALA A 227
ASN A 232
None
1.24A 4u14A-5mfaA:
undetectable
4u14A-5mfaA:
20.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5x7h CYCLOISOMALTOOLIGOSA
CCHARIDE
GLUCANOTRANSFERASE


(Paenibacillus
sp. 598K)
PF13199
(Glyco_hydro_66)
PF16990
(CBM_35)
5 ASP A  59
TYR A  55
SER A 113
THR A 135
ALA A 123
None
1.48A 4u14A-5x7hA:
undetectable
4u14A-5x7hA:
20.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6bgi ANOCTAMIN-1

(Mus musculus)
no annotation 5 THR A 535
ALA A 538
ALA A 517
ASN A 542
TYR A 594
None
1.07A 4u14A-6bgiA:
3.2
4u14A-6bgiA:
11.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6bk1 UDP-GLYCOSYLTRANSFER
ASE 79


(Oryza sativa)
no annotation 5 ILE A 389
ASP A 385
THR A 196
ALA A 192
ALA A 191
None
1.49A 4u14A-6bk1A:
undetectable
4u14A-6bk1A:
10.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6c26 DOLICHYL-DIPHOSPHOOL
IGOSACCHARIDE--PROTE
IN
GLYCOSYLTRANSFERASE
SUBUNIT STT3


(Saccharomyces
cerevisiae)
no annotation 5 ILE A 253
TYR A 203
SER A 206
ALA A 169
ALA A 171
EGY  C 301 ( 4.7A)
EGY  C 301 (-4.6A)
EGY  C 301 ( 3.9A)
None
None
1.37A 4u14A-6c26A:
undetectable
4u14A-6c26A:
10.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6gi2 FERRIC ENTEROBACTIN
ESTERASE


(Pseudomonas
aeruginosa)
no annotation 5 SER A  29
THR A 104
ALA A 125
ALA A 127
TYR A  88
None
1.35A 4u14A-6gi2A:
undetectable
4u14A-6gi2A:
12.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1bix AP ENDONUCLEASE 1

(Homo sapiens)
PF03372
(Exo_endo_phos)
4 ASN A 277
LEU A 305
PHE A 266
TYR A 269
None
1.38A 4u14A-1bixA:
undetectable
4u14A-1bixA:
19.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1r4n AMYLOID BETA
PRECURSOR
PROTEIN-BINDING
PROTEIN 1


(Homo sapiens)
PF00899
(ThiF)
4 ASN A 517
LEU A 398
PHE A 532
TYR A 161
None
1.29A 4u14A-1r4nA:
undetectable
4u14A-1r4nA:
21.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2cov BETA-1,3-XYLANASE

(Alcaligenes sp.
XY-234)
PF11606
(AlcCBM31)
4 ASN D 389
LEU D 436
PHE D 432
TYR D 440
None
1.47A 4u14A-2covD:
undetectable
4u14A-2covD:
11.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2gs8 MEVALONATE
PYROPHOSPHATE
DECARBOXYLASE


(Streptococcus
pyogenes)
PF00288
(GHMP_kinases_N)
PF08544
(GHMP_kinases_C)
4 ASN A  13
LEU A 217
PHE A 147
TYR A 161
None
1.34A 4u14A-2gs8A:
0.0
4u14A-2gs8A:
18.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2qua EXTRACELLULAR LIPASE

(Serratia
marcescens)
no annotation 4 ASN A 285
LEU A 323
PHE A 371
TYR A 332
CA  A 620 (-3.3A)
None
None
None
1.41A 4u14A-2quaA:
0.0
4u14A-2quaA:
21.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3a98 ENGULFMENT AND CELL
MOTILITY PROTEIN 1


(Homo sapiens)
PF16457
(PH_12)
4 ASN B 653
LEU B 638
PHE B 562
TYR B 662
None
1.50A 4u14A-3a98B:
0.0
4u14A-3a98B:
18.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3b46 AMINOTRANSFERASE
BNA3


(Saccharomyces
cerevisiae)
PF00155
(Aminotran_1_2)
4 ASN A 205
LEU A 361
PHE A 148
TYR A 407
LLP  A 271 ( 3.2A)
None
None
None
1.20A 4u14A-3b46A:
0.0
4u14A-3b46A:
22.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3h7n NUCLEOPORIN NUP120

(Saccharomyces
cerevisiae)
PF11715
(Nup160)
4 ASN A 120
LEU A  60
PHE A  72
TYR A  56
None
1.46A 4u14A-3h7nA:
2.7
4u14A-3h7nA:
20.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3js8 CHOLESTEROL OXIDASE

(Chromobacterium
sp. DS-1)
PF01565
(FAD_binding_4)
PF09129
(Chol_subst-bind)
4 ASN A 294
LEU A 330
PHE A 287
TYR A 348
None
1.43A 4u14A-3js8A:
0.0
4u14A-3js8A:
22.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3on7 OXIDOREDUCTASE,
IRON/ASCORBATE
FAMILY


(Shewanella
oneidensis)
PF03171
(2OG-FeII_Oxy)
PF14226
(DIOX_N)
4 ASN A  61
LEU A 150
PHE A  68
TYR A  88
None
1.17A 4u14A-3on7A:
0.0
4u14A-3on7A:
21.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3wel ALPHA-GLUCOSIDASE

(Beta vulgaris)
PF01055
(Glyco_hydro_31)
PF13802
(Gal_mutarotas_2)
PF16863
(NtCtMGAM_N)
4 ASN A 758
LEU A 656
PHE A 724
TYR A 729
None
None
None
GOL  A1009 (-3.6A)
1.31A 4u14A-3welA:
undetectable
4u14A-3welA:
18.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3whd C-TYPE LECTIN DOMAIN
FAMILY 4 MEMBER D


(Homo sapiens)
PF00059
(Lectin_C)
4 ASN A 129
LEU A 143
PHE A 134
TYR A  96
None
1.42A 4u14A-3whdA:
undetectable
4u14A-3whdA:
17.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4giz MALTOSE-BINDING
PERIPLASMIC PROTEIN,
UBIQUITIN LIGASE
EA6P: CHIMERIC
PROTEIN
PROTEIN E6


(Alphapapillomavirus
9;
Escherichia
coli;
Homo sapiens)
PF00518
(E6)
PF01547
(SBP_bac_1)
4 ASN C 105
LEU A 379
PHE C  69
TYR C  32
None
1.49A 4u14A-4gizC:
undetectable
4u14A-4gizC:
14.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4gkf CRISPR SYSTEM CMR
SUBUNIT CMR5


(Pyrococcus
furiosus)
PF09701
(Cas_Cmr5)
4 ASN A 148
LEU A 107
PHE A 153
TYR A  25
None
1.25A 4u14A-4gkfA:
0.3
4u14A-4gkfA:
16.56
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4u16 MUSCARINIC
ACETYLCHOLINE
RECEPTOR
M3,LYSOZYME,MUSCARIN
IC ACETYLCHOLINE
RECEPTOR M3


(Escherichia
virus T4;
Rattus
norvegicus)
PF00001
(7tm_1)
PF00959
(Phage_lysozyme)
4 ASN A 152
LEU A 225
PHE A 239
TYR A 506
None
None
None
3C0  A1202 (-3.7A)
0.43A 4u14A-4u16A:
36.2
4u14A-4u16A:
89.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4wts BETA-1,3-GLUCANOSYLT
RANSFERASE


(Rhizomucor
miehei)
PF00332
(Glyco_hydro_17)
4 ASN A 152
LEU A 227
PHE A 245
TYR A 212
BGC  A 303 (-4.1A)
None
BGC  A 303 ( 4.4A)
None
1.35A 4u14A-4wtsA:
undetectable
4u14A-4wtsA:
20.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4zps MCG133388, ISOFORM
CRA_M


(Mus musculus)
PF00028
(Cadherin)
PF08266
(Cadherin_2)
4 ASN A  78
LEU A  23
PHE A  46
TYR A   4
None
1.27A 4u14A-4zpsA:
undetectable
4u14A-4zpsA:
20.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5b0n E3 UBIQUITIN-PROTEIN
LIGASE IPAH9.8


(Shigella
flexneri)
PF12468
(TTSSLRR)
4 ASN A 214
LEU A 152
PHE A 187
TYR A 186
None
1.30A 4u14A-5b0nA:
undetectable
4u14A-5b0nA:
18.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5b3h PROTEIN SCARECROW

(Arabidopsis
thaliana)
PF03514
(GRAS)
4 ASN A 374
LEU A 548
PHE A 382
TYR A 625
None
1.42A 4u14A-5b3hA:
undetectable
4u14A-5b3hA:
20.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5cd2 ENDO-1,4-D-GLUCANASE

(Aliivibrio
fischeri)
PF01270
(Glyco_hydro_8)
4 ASN A 360
LEU A 271
PHE A  52
TYR A  79
None
1.45A 4u14A-5cd2A:
0.0
4u14A-5cd2A:
21.90
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5dsg MUSCARINIC
ACETYLCHOLINE
RECEPTOR
M4,ENDOLYSIN,ENDOLYS
IN,MUSCARINIC
ACETYLCHOLINE
RECEPTOR M4


(Escherichia
virus T4;
Homo sapiens)
PF00001
(7tm_1)
PF00959
(Phage_lysozyme)
4 ASN A 117
LEU A 190
PHE A 204
TYR A 416
OLC  A1208 ( 3.6A)
P6G  A1205 (-4.6A)
None
0HK  A1201 (-4.2A)
0.31A 4u14A-5dsgA:
41.2
4u14A-5dsgA:
67.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ewt EXODEOXYRIBONUCLEASE
III XTH


(Sulfolobus
islandicus)
PF03372
(Exo_endo_phos)
4 ASN A   7
LEU A 210
PHE A 106
TYR A 214
None
1.23A 4u14A-5ewtA:
undetectable
4u14A-5ewtA:
20.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5j68 ASTROTACTIN-2

(Homo sapiens)
PF01823
(MACPF)
4 ASN A 751
LEU A 727
PHE A 756
TYR A 859
None
1.39A 4u14A-5j68A:
undetectable
4u14A-5j68A:
21.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5mpd 26S PROTEASOME
REGULATORY SUBUNIT
RPN7


(Saccharomyces
cerevisiae)
PF01399
(PCI)
PF10602
(RPN7)
4 ASN R  23
LEU R 154
PHE R 179
TYR R 186
None
1.40A 4u14A-5mpdR:
0.0
4u14A-5mpdR:
21.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5n5d METHYLTRANSFERASE

(Streptomyces
regensis)
PF01596
(Methyltransf_3)
4 ASN A 166
LEU A  49
PHE A  67
TYR A  70
None
BU3  A 301 ( 3.7A)
SAM  A 306 (-4.2A)
None
1.40A 4u14A-5n5dA:
undetectable
4u14A-5n5dA:
18.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5opt 40S RIBOSOMAL
PROTEIN S3A-2


(Trypanosoma
cruzi)
no annotation 4 ASN W  37
LEU W 230
PHE W 102
TYR W 135
None
1.45A 4u14A-5optW:
undetectable
4u14A-5optW:
20.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5szm PCDHGA8 OR
PROTOCADHERIN GAMMA
A8


(Mus musculus)
PF00028
(Cadherin)
PF08266
(Cadherin_2)
4 ASN A  78
LEU A  23
PHE A  46
TYR A   4
None
1.26A 4u14A-5szmA:
undetectable
4u14A-5szmA:
22.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5u9e HTH-TYPE
TRANSCRIPTIONAL
ACTIVATOR RHAR


(Bacteria
Latreille et
al. 1825)
no annotation 4 ASN A  86
LEU A 155
PHE A  66
TYR A  67
RM4  A 201 (-2.4A)
None
None
None
1.39A 4u14A-5u9eA:
undetectable
4u14A-5u9eA:
10.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5vc2 SERINE
HYDROXYMETHYLTRANSFE
RASE


(Helicobacter
pylori)
PF00464
(SHMT)
4 ASN A  99
LEU A 194
PHE A 171
TYR A 142
None
1.41A 4u14A-5vc2A:
undetectable
4u14A-5vc2A:
21.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5vhi 26S PROTEASOME
NON-ATPASE
REGULATORY SUBUNIT 2


(Homo sapiens)
PF00004
(AAA)
4 ASN f 371
LEU f 391
PHE f 376
TYR f 751
None
1.11A 4u14A-5vhif:
undetectable
4u14A-5vhif:
18.86